- Home
- DARE
DARE
Dare Bioscience Inc.
as 04-18-2025 1:34pm EST
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $20.33 | AVG Volume (30 days): | 19.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.67 - $7.56 | Next Earning Date: | 05-13-2025 |
| Revenue: | $9,784 | Revenue Growth: | -99.65% |
| Revenue Growth (this year): | 11398.36% | Revenue Growth (next year): | 1808.62% |
Latest Dare Bioscience Inc. News
DARE Breaking Stock News: Dive into DARE Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
Daré Bioscience to Present at the Jones Healthcare and Technology Innovation Conference on Expanded Business Strategy Including Action to Make its Proprietary Sildenafil Cream Formulation Available via Prescription This Year
Thomson Reuters StreetEvents
18 days ago
Q4 2024 Dare Bioscience Inc Earnings Call
GuruFocus.com
18 days ago
Dare Bioscience Inc (DARE) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial ...
Zacks
19 days ago
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates
GlobeNewswire
19 days ago
Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update
GlobeNewswire
a month ago
Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025
GlobeNewswire
2 months ago
Daré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant
GlobeNewswire
2 months ago
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
Compare DARE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DARE Dare Bioscience Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.